The present findings provide evidence for a molecular action of Antho 50 in CLL involving activation of the caspase 3-related apoptotic pathway, as a result of down-regulation of Bcl-2 subsequent to Bad dephosphorylation. This evidence concerns the gene BAD and B-cell chronic lymphocytic leukemia.